Bezafibrate for the treatment of dyslipidemia in patients with coronary artery disease: 20-year mortality follow-up of the BIP randomized control trial

BACKGROUND: Recent data support the renewed interest in hypertriglyceridemia as a possible important therapeutic target for cardiovascular risk reduction. This study was designed to address the question of all-cause mortality during extended follow-up of the BIP trial in patients stratified by basel...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cardiovasc Diabetol
Autors principals: Arbel, Yaron, Klempfner, Robert, Erez, Aharon, Goldenberg, Ilan, Benzekry, Sagit, Shlomo, Nir, Fisman, Enrique Z., Tenenbaum, Alexander
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2016
Matèries:
Original Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4722704/
https://ncbi.nlm.nih.gov/pubmed/26794137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-016-0332-6
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars